Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. حسب Bei Wang (116772)

Decrease in vRNA in brain during antiretroviral therapy. حسب Sonny R. Elizaldi (9684796)

Effect of Safr and Cands on the levels of 5-hydroxytryptamine (5-HT, μg/g tissue), 5-hydroxyindoleacetic acid (5-HIAA, μg/g tissue), norepinephrine (NE, μg/g tissue) and dopamine (... حسب Nagwa Ibrahim Shehata (17319689)

This is the raw data of Immunofluorescence in Met-5A cell. حسب Yangyang Yin (14323701)

الموضوعات:

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. حسب Joseph Rabin (7399436)

الموضوعات:

This is the raw data of Western blot in Met-5A cell. حسب Yangyang Yin (14323701)

الموضوعات:

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. حسب Luca G. Valente (12463057)

Fig 5 - حسب Andrea R. Thurman (5286005)

Fig 5 - حسب Shivankar Agrawal (11565095)

الموضوعات:

MiR-132-3p was downregulated in TGF-<i>β</i>1 stimulated Met-5A cells and miR-132-3p mimics and miR-132-3p inhibitor transfected Met-5A cells. حسب Yangyang Yin (14323701)

الموضوعات:

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades حسب Ihab Shawish (13015516)

الموضوعات:

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades حسب Ihab Shawish (13015516)

الموضوعات:

Flowchart of study selection. حسب Alejandro Piscoya (782326)

الموضوعات:

Description of characteristics of included studies. حسب Alejandro Piscoya (782326)

الموضوعات:

Effect of remdesivir on invasive ventilation at 14 days. حسب Alejandro Piscoya (782326)

الموضوعات:

Effect of remdesivir on all-cause mortality at 14 days. حسب Alejandro Piscoya (782326)

الموضوعات:

Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)

الموضوعات:

Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. حسب Alejandro Piscoya (782326)

الموضوعات:

Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)

الموضوعات:

This is the raw data of IHC-2 、qPCR、Masson and HE in Rat、qPCR in human peritoneal solution and qPCR in Met-5A cell. حسب Yangyang Yin (14323701)

الموضوعات: